de Abreu, Paloma <br/><br/>
Safety and Survival Associated with Biologic Therapies: First Report of the Biobadaguay on the Paraguayan-Uruguayan Registry of Adverse Events with Biologic Therapies.  [electronic resource] 

 -  Reumatologia clinica   
 - 396-404 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>2173-5743 
<br/><br/><label>Standard No.: </label>10.1016/j.reuma.2018.08.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--adverse effects<br/>Adult<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Antirheumatic Agents--adverse effects<br/>Arthritis, Juvenile--drug therapy<br/>Arthritis, Rheumatoid--drug therapy<br/>Biological Products--adverse effects<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Paraguay<br/>Prospective Studies<br/>Registries<br/>Survival Rate<br/>Uruguay